In vitro infection and type-restricted antibody-mediated neutralization of authentic human papillomavirus type 16

Journal of Virology

Volumn 72, Issue 2, 1998, Pages 959-964

  White, Wendy I ^a,c   Wilson, Susan D ^a   Bonnez, William ^b   Rose, Robert C ^b   Koenig, Scott ^a   Suzich, Joann A ^a  

^a MEDIMMUNE   (United States)

^b UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

^c NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRAL ACTIVITY; ARTICLE; CANCER RISK; NONHUMAN; PRIORITY JOURNAL; UTERINE CERVIX CANCER; VIRUS CARCINOGENESIS; VIRUS ISOLATION; WART VIRUS;

EID: 0031905637     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.72.2.959-964.1998     Document Type: Article

References (38)

1. Bauer, H. M., C. E. Greer, and M. M. Manos. 1992. Detection of genital human papillomavirus using PCR, p. 131-152. In C. S. Herrington and J. O. McGee (ed.), Diagnostic molecular pathology: a practical approach. Oxford University Press, Oxford, United Kingdom.
2. Bonnez, W., C. Da Rin, C. Borkhuis, K. de Mesy Jensen, R. C. Reichman, and R. C. Rose. Isolation and propagation of human papillomavirus type 16 in human xenografts implanted in the severe combined immunodeficiency mouse. Submitted for publication.
3. Bonnez, W., R. C. Rose, C. Da Rin, C. Borkhuis, K. L. de Mesy Jensen, and R. C. Reichman. 1993. Propagation of human papillomavirus type 11 in human xenografts using the severe combined immunodeficiency (SCID) mouse and comparison to the nude mouse model. Virology 197:455-458.
4. Bonnez, W., R. C. Rose, and R. C. Reichman. 1992. Antibody-mediated neutralization of human papillomavirus type 11 (HPV-11) infection in the nude mouse: detection of HPV-11 mRNAs. J. Infect. Dis. 165:376-380.
5. Bosch, F. X., M. M. Manos, N. Munoz, M. Sherman, A. M. Jansen, J. Petro, M. H. Schifman, V. Moreno, R. Kurman, and K. V. Shah. 1995. Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. J. Natl. Cancer Inst. 87:796-802.
6. Boukamp, P., R. T. Petrussevska, D. Breikreutz, J. Hornung, A. Markham, and N. E. Fusenig. 1988. Normal keratinization in a spontaneously immortalized aneuploid human keratinocyte cell line. J. Cell Biol. 106:761-771.
7. Breitburd, F., R. Kirnbauer, N. L. Hubbert, B. Nonnenmacher, C. Trin-Dinh-Desmarquet, G. Orth, J. T. Schiller, and D. R. Lowy. 1995. Immunization with viruslike particles from cottontail rabbit papillomavirus (CRPV) can protect against experimental CRPV infection. J. Virol. 69:3959-3963.
8. Chow, L. T., M. Nasseri, S. M. Wolinsky, and T. R. Broker. 1987. Human papillomavirus types 6 and 11 mRNAs from genital condylomata acuminata. J. Virol. 61:2581-2588.
9. Chow, L. T., S. S. Reilly, T. R. Broker, and L. B. Taichman. 1987. Identification and mapping of human papillomavirus type 1 RNA transcripts recovered from plantar warts and infected epithelial cell cultures. J. Virol. 61: 1913-1918.
10. Christensen, N. D., N. M. Cladel, and C. A. Reed. 1995. Postattachment neutralization of papillomaviruses by monoclonal and polyclonal antibodies. Virology 207:136-142.
11. Christensen, N. D., C. A. Reed, N. M. Cladel, K. Hall, and G. S. Leiserowitz. 1996. Monoclonal antibodies to HPV-6 L1 virus-like particles identify conformational and linear epitopes on HPV-11 in addition to type-specific epitopes on HPV-6. Virology 22:477-486.
12. Christensen, N. D., and J. W. Kreider. 1990. Antibody-mediated neutralization in vivo of infectious papillomavirus. J. Virol. 64:3151-3156.
13. Christensen, N. D., and J. W. Kreider. 1991. Neutralization of CRPV infectivity by monoclonal antibodies that identify conformational epitopes on intact virions. Virus Res. 21:169-179.
14. Christensen, N. D., J. W. Kreider, N. M. Cladel, S. D. Patrick, and P. A. Welsh. 1990. Monoclonal antibody-mediated neutralization of infectious human papillomavirus type 11. J. Virol. 64:5678-5681.
15. Ghim, S., N. D. Christenen, J. W. Kreider, and A. B. Jenson. 1991. Comparison of neutralization of BPV-1 infection of C127 cells and bovine fetal skin xenografts. Int. J. Cancer 49:285-289.
16. Hagensee, M. E., N. Yaegashi, and D. A. Galloway. 1993. Self-assembly of human papillomavirus type 1 capsids by expression of the L1 protein alone or by coexpression of the L1 and L2 capsid proteins. J. Virol. 67:315-322.
17. Hildesheim, A., M. H. Schiffman, P. E. Gravitt, A. G. Glass, C. E. Greer, T. Zhang, D. R. Scott, B. B. Rush, P. Lawler, M. E. Sherman, R. J. Kurman, and M. M. Manos. 1994. Persistence of type-specific human papillomavirus infection among cytologically normal women. J. Infect. Dis. 169:235-240.
18. Kirnbauer, R., F. Booy, N. Cheng, D. R. Lowy, and J. T. Schiller. 1992. Papillomavirus L1 major capsid protein self-assembles into virus-like particles that are highly immunogenic. Proc. Natl. Acad. Sci. USA 89:12180-12184.
19. Kirnbauer, R., L. M. Chandrachud, B. W. O'Neil, E. R. Wagner, G. J. Grindlay, A. Armstrong, G. M. McGarvie, J. T. Schiller, D. R. Lowy, and M. S. Campo. 1996. Virus-like particles of bovine papillomavirus type 4 in prophylactic and therapeutic immunization. Virology 219:37-44.
20. Kreider, J. W., M. K. Howett, A. E. Leure-Dupree, R. J. Zaino, and J. A. Weber. 1987. Laboratory production in vivo of infectious human papillomavirus type 11. J. Virol. 61:590-593.
21. Manos, M. M., Y. Ting, A. J. Lewis, T. R. Broker, and S. M. Wolinsky. 1989. Use of polymerase chain reaction amplification for the detection of genital human papillomaviruses. Cancer Cells 7:209-214.
22. Manos, M. M., J. Waldman, T. Y. Zhang, C. G. Greer, M. H. Eichinger, M. H. Schiffman, and C. M. Wheeler. 1994. Epidemiology and partial nucleotide sequence of four novel genital human papillomaviruses. J. Infect. Dis. 170:1096-1099.
23. Meyer, T., R. Arndt, E. Stockfleth, H. T. Flammann, H. Wolf, and U. Reischl. 1995. Strategy for typing human papillomaviruses by RFLP analysis of PCR fragments and subsequent hybridization with a generic probe. BioTechniques 19:632-639.
24. Nasseri, M., R. Hirochika, T. R. Broker, and L. T. Chow. 1987. A human papillomavirus type 11 transcript encoding an E1 ∧ E4 fusion protein. Virology 159:433-439.
25. Palermo-Dilts, D. A., T. R. Broker, and L. T. Chow. 1990. Human papillomavirus type 1 produces redundant as well as polycistronic mRNAs in plantar warts. J. Virol. 64:3144-3149.
26. Phelps, W. C., and K. A. Alexander. 1995. Antiviral therapy for human papillomaviruses: rationale and prospects. Ann. Intern. Med. 123:368-382.
27. Roden, R. B. S., H. L. Greenstone, R. Kirnbauer, F. P. Booy, J. Jessie, D. R. Lowy, and J. T. Schiller. 1996. In vitro generation and type-specific neutralization of a human papillomavirus type 16 virion pseudotype. J. Virol. 70: 5875-5883.
28. Roden, R. B. S., N. L. Hubbert, R. Kirnbauer, N. D. Christensen, D. R. Lowy, and J. T. Schiller. 1996. Assessment of the serological relatedness of genital human papillomaviruses by hemagglutination inhibition. J. Virol. 70:3298-3301.
29. Roden, R. B. S., E. M. Weissinger, D. W. Henderson, F. Booy, R. Kirnbauer, J. F. Mushinski, D. R. Lowy, and J. T. Schiller. 1994. Neutralization of bovine papillomavirus by antibodies to L1 and L2 capsid proteins. J. Virol. 68:7570-7574.
30. Rose, R. C., W. Bonnez, C. Da Rin, D. J. McCance, and R. C. Reichman. 1994. Serological differentiation of human papillomavirus types 11, 16 and 18 using recombinant virus-like particles. J. Gen. Virol. 75:2445-2449.
31. Rose, R. C., W. Bonnez, R. C. Reichman, and R. L. Garcea. 1993. Expression of human papillomavirus type 11 L1 protein in insect cells: in vivo and in vitro assembly of viruslike particles. J. Virol. 67:1936-1944.
32. Seedorf, K., G. Krämmer, M. Dürst, S. Suhai, and W. G. Röwekamp. 1985. Human papillomavirus type 16 DNA sequence. Virology 145:181-185.
33. Smith, L. H., C. Foster, M. E. Hitchcock, and R. Isseroff. 1993. In vitro HPV-11 infection of human foreskin. J. Invest. Dermatol. 101:292-295.
34. Smith, L. H., C. Foster, M. E. Hitchcock, G. S. Leiserowitz, K. Hall, R. Isseroff, N. D. Christensen, and J. W. Kreider. 1995. Titration of HPV-11 infectivity and antibody neutralization can be measured in vitro. J. Invest. Dermatol. 105:1-7.
35. Suzich, J. S., S.-J. Ghim, F. J. Palmer-Hill, W. I. White, J. K. Tamura, J. A. Bell, J. A. Newsome, A. Bennett Jenson, and R. Schlegel. 1995. Systemic immunization with papillomavirus Ll protein completely prevents the development of viral mucosal papillomas. Proc. Natl. Acad. Sci. USA 92: 11553-11557.
36. Tanaka, A., T. Noda, H. Yajima, M. Hatanaka, and Y. Ito. 1989. Identification of a transforming gene of human papillomavirus type 16. J. Virol. 63:1465-1469.
37. Taniguchi, A., and S. Yasumoto. 1990. A major transcript of human papillomavirus type 16 in transformed NIH 3T3 cells contains polycistronic mRNA encoding E7, E5, and E1 ∧ E4 fusion gene. Virus Genes 3:221-233.
38. Unckell, F., R. E. Streeck, and M. Sapp. 1997. Generation and neutralization of pseudovirions of human papillomavirus type 33. J. Virol. 71:2934-2939.